Study of BioNIR Drug Eluting Stent System in Coronary Stenosis

NACompletedINTERVENTIONAL
Enrollment

1,919

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 28, 2016

Study Completion Date

November 30, 2020

Conditions
Coronary Artery Stenosis
Interventions
DEVICE

BioNIR

drug-eluting stent

DEVICE

Resolute

drug-eluting stent

Trial Locations (8)

20162

San Raffaele Hospital, Milan

30309

Piedmont Healthcare, Atlanta

36200

Hospital Meixoeiro, Pontevedra

91120

Hadassah Hebrew University Medical Center, Jerusalem

Unknown

ZNA Middelheim, Antwerp

B3H 3A7

Queen Elizabeth II Health Sciences Centre, Halifax

3079 DZ

Maasstad Ziekenhuis, Rotterdam

43-316

PAKS, II Oddzial Kardiologiczny, Bielsko-Biala

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medinol Ltd.

INDUSTRY

NCT01995487 - Study of BioNIR Drug Eluting Stent System in Coronary Stenosis | Biotech Hunter | Biotech Hunter